#1 Clinical Trials Search in Europe

ISPAGHULA HUSK

Ispaghula husk, also known as Plantago ovata husk or psyllium husk, has been the subject of several clinical trials investigating its potential health benefits. This natural soluble fiber has shown promise in addressing various health conditions including metabolic syndrome in children, hypercholesterolemia, Parkinson’s disease management, and digestive disorders like irritable bowel syndrome. These trials have explored how this plant-based supplement can work either alone or in combination with other treatments to improve patient outcomes. This article summarizes the key findings from recent clinical research on ispaghula husk and its therapeutic applications.

Table of Contents

What is Ispaghula Husk?

Ispaghula husk, also known as Plantago ovata husk or psyllium husk, is a type of soluble fiber derived from the seeds of the Plantago ovata plant. In some regions, it is also referred to as Ispaghol. This natural fiber supplement is resistant to digestion by human gastrointestinal enzymes, meaning it passes through your digestive system largely intact.[1]

Ispaghula husk works by absorbing water in the intestines, forming a gel-like substance that can help regulate bowel movements and provide various health benefits. It is commonly available as effervescent powder, which is mixed with water before consumption.[2]

Health Conditions Treated with Ispaghula Husk

Clinical trials have investigated the effectiveness of ispaghula husk in treating several health conditions. The following sections detail the specific conditions for which this fiber supplement may be beneficial.

Ispaghula Husk for Metabolic Syndrome

Metabolic syndrome is a cluster of conditions that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes. These conditions include increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels.[1]

Research suggests that ispaghula husk may help in the management of metabolic syndrome, particularly in children and adolescents. A multicenter, double-blind, randomized controlled trial with placebo has been conducted to evaluate the effect of ispaghula husk treatment on the remission of metabolic syndrome in children between 10 to 16 years old.[1]

The treatment consisted of one sachet of effervescent powder containing 5 grams of product (3.5 g of ispaghula husk), taken twice daily for 16 weeks. The main outcome measured was the remission of metabolic syndrome following the International Diabetes Federation (IDF) criteria for children, which includes a reduction in waist circumference to lower than the 90th percentile for the population according to age.[1]

Secondary outcomes measured in this study included changes in:

  • Body weight – tracking whether participants lost weight during treatment
  • Lipid profile – measuring changes in cholesterol and other blood fats
  • Insulin resistance – using the HOMA index to assess how well the body processes insulin
  • Inflammatory parameters – such as C-reactive protein (CRP), interleukins, and adiponectin
  • Blood pressure – monitoring changes in systolic and diastolic readings

This research suggests that ispaghula husk may be effective in addressing multiple components of metabolic syndrome simultaneously.[1]

Ispaghula Husk for High Cholesterol

Hypercholesterolemia (high blood cholesterol) is a major risk factor for heart disease, myocardial infarction, and angina pectoris. These conditions represent a leading cause of death in Western countries.[2]

Studies have shown that consumption of soluble fiber like ispaghula husk can help reduce cholesterol levels. A multicenter, comparative, double-blind clinical trial has been conducted to evaluate the effects of ispaghula husk treatment on the lipid profile of patients with hypercholesterolemia.[2]

The primary goal of this study was to determine whether ispaghula husk could reduce low-density lipoprotein cholesterol (LDL-c, often called “bad cholesterol”) by 5% when added to a low saturated fat diet in patients with moderate hypercholesterolemia.[2]

Secondary outcomes included:

  • Evaluating the combined cholesterol-lowering effect of ispaghula husk with statins (common cholesterol-lowering medications)
  • Analyzing the effect of ispaghula husk on blood pressure
  • Assessing whether genetic factors affected the response to treatment

This research suggests that ispaghula husk may be an effective addition to dietary changes for managing cholesterol levels, potentially reducing the need for higher doses of medication.[2]

Ispaghula Husk in Parkinson’s Disease

Parkinson’s disease is a progressive neurological disorder that affects movement. While levodopa (L-dopa) is the standard treatment for Parkinson’s disease, many patients develop motor complications, including fluctuations and dyskinesia (involuntary movements), after several years of treatment.[3]

These complications may be partly due to pharmacokinetic factors – how the drug is absorbed, distributed, and eliminated from the body. More stable blood levels of L-dopa could potentially improve response to treatment and reduce adverse reactions.[3]

Initial animal studies showed that ispaghula husk influences the pharmacokinetic parameters of L-dopa, helping to maintain more stable blood levels. A clinical trial has been conducted to study how ispaghula husk modifies the absorption and elimination of L-dopa in patients with recently diagnosed Parkinson’s disease who are being treated with levodopa/carbidopa.[3]

The treatment consisted of 5 grams of effervescent powder (containing 3.5 grams of ispaghula husk) taken three times daily for 14 days. The study also evaluated whether ispaghula husk treatment affected biochemical parameters such as total cholesterol, HDL, LDL, and blood glucose levels.[3]

This research suggests that ispaghula husk may help improve the effectiveness of Parkinson’s disease treatment by stabilizing medication levels in the bloodstream.[3]

Ispaghula Husk for Digestive Disorders

Ispaghula husk has shown promise in the management of various digestive disorders, including irritable bowel syndrome with diarrhea (IBS-D) and fecal incontinence.

Irritable Bowel Syndrome with Diarrhea (IBS-D)

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits. IBS-D is a subtype where diarrhea is the predominant symptom.[4]

A clinical trial has compared the efficacy of different drug combinations for managing IBS-D, including a combination of rifaximin (an antibiotic) and ispaghula husk. The study assessed improvements in:

  • Stool frequency – measuring the reduction in number of stools per day
  • Stool characteristics – evaluating changes in stool consistency according to the Bristol Stool Chart
  • Abdominal pain – assessing pain reduction

This research suggests that ispaghula husk, when combined with other treatments, may help manage symptoms of IBS-D.[4]

Fecal Incontinence

Fecal incontinence is the inability to control bowel movements, causing stool to leak unexpectedly from the rectum. It affects 2-13% of the general adult population, with prevalence increasing with age. After age 50, prevalence rates up to 26% in women have been reported.[5]

Ispaghula husk has been studied as part of standard treatment for fecal incontinence, often in combination with other approaches such as biofeedback, medications like loperamide, and in some cases, percutaneous tibial nerve stimulation (PTNS).[5]

As a stool bulking agent, ispaghula husk helps to add consistency to loose stool, making it easier for patients to maintain bowel control. This can significantly improve quality of life for those suffering from this condition.[5]

Dosage and Administration

Based on the clinical trials reviewed, the dosage of ispaghula husk varies depending on the condition being treated:

  • For metabolic syndrome: One sachet of effervescent powder containing 5 grams of product (3.5 g of ispaghula husk), twice daily.[1]
  • For Parkinson’s disease patients: 5 grams of effervescent powder (containing 3.5 grams of ispaghula husk) three times daily.[3]
  • For irritable bowel syndrome with diarrhea: 15-30 mg once daily (often combined with other medications).[4]

Ispaghula husk is typically taken orally, with the powder mixed in water to create an effervescent drink. It’s important to drink plenty of water when taking ispaghula husk to prevent it from swelling and blocking your throat or intestines.[1][3]

Potential Side Effects

While ispaghula husk is generally well-tolerated, potential side effects may include:

  • Bloating – temporary increase in abdominal distension
  • Stomachache – mild abdominal discomfort
  • Constipation – especially if not taken with sufficient water
  • Heartburn – acid reflux symptoms

It’s important to start with a lower dose and gradually increase it to reduce the risk of digestive discomfort. Always take ispaghula husk with plenty of water to prevent choking or intestinal blockage.[4]

If you experience severe abdominal pain, difficulty swallowing, or chest pain after taking ispaghula husk, seek immediate medical attention as these could indicate a serious adverse reaction.[4]

Clinical Trial Focus Condition Intervention Dosage Duration Primary Outcome Measure
Metabolic Syndrome in Children Metabolic Syndrome Ispaghula husk vs. Placebo 3.5g twice daily 16 weeks Remission of metabolic syndrome according to IDF criteria
Cholesterol Management Hypercholesterolemia Plantago ovata husk Not specified Not specified 5% reduction in LDL cholesterol levels
Parkinson’s Disease Idiopathic Parkinson’s Disease Plantago ovata husk vs. Placebo 3.5g three times daily 14 days Modification of levodopa pharmacokinetic parameters
Irritable Bowel Syndrome IBS with Diarrhea Rifaximin + Psyllium Husk vs. other combinations 15-30mg once daily 2 weeks Improvement in diarrhea frequency, stool characteristics, and abdominal pain
Fecal Incontinence Fecal Incontinence Standard treatment including stool bulking agent (sterculia or ispaghula husk) Not specified Not specified Change in fecal leakage episodes

FAQ

  • What is Ispaghula husk and how does it work? Ispaghula husk (also called Plantago ovata husk or psyllium husk) is a soluble fiber derived from the seeds of the Plantago ovata plant. It works by absorbing water in the intestines to form a gel-like substance that can help regulate bowel movements. In the body, it can help lower cholesterol levels, stabilize blood sugar, and promote feelings of fullness. Its effects come from its ability to slow digestion and bind to substances in the digestive tract.
  • What conditions has Ispaghula husk been studied for in clinical trials? According to the clinical trials data, Ispaghula husk has been studied for several conditions including: metabolic syndrome in children and adolescents, hypercholesterolemia (high cholesterol), Parkinson's disease (to modify levodopa pharmacokinetics), irritable bowel syndrome with diarrhea, and fecal incontinence. These studies examined how this fiber might help improve these conditions either alone or in combination with other treatments.
  • How is Ispaghula husk administered in clinical trials? In the clinical trials, Ispaghula husk was typically administered orally in the form of effervescent powder in sachets. The dosages varied by study: for metabolic syndrome, patients received one sachet containing 5 grams of product (3.5 g of Ispaghula husk) twice daily for 16 weeks; for Parkinson's disease, 5 grams of effervescent powder (3.5 g of Ispaghula husk) three times daily for 14 days; and for irritable bowel syndrome, 15-30mg once daily for 2 weeks. It was always taken orally with water.
  • What were the results of using Ispaghula husk for metabolic syndrome in children? The clinical trial for metabolic syndrome in children and adolescents aimed to determine if Ispaghula husk could help achieve remission of metabolic syndrome. The study measured several outcomes including changes in body weight, lipid profile, insulin resistance, inflammatory parameters, and blood pressure. The primary goal was to see if treatment with Ispaghula husk for 4 months could reduce waist circumference to below the 90th percentile according to International Diabetes Federation criteria. Full results of this particular trial were not provided in the data, but the study was designed to compare Ispaghula husk against placebo.
  • Can Ispaghula husk be used alongside other medications? Yes, several clinical trials have studied Ispaghula husk in combination with other medications. In the hypercholesterolemia study, researchers examined its cholesterol-lowering effects when combined with statins. In the Parkinson's disease trial, it was studied for its ability to modify the pharmacokinetics of levodopa/carbidopa. In the irritable bowel syndrome trial, it was combined with Rifaximin and compared to other drug combinations. These studies suggest that Ispaghula husk can be used as complementary therapy alongside other medications, though patients should always consult healthcare providers before combining treatments.

Ongoing Clinical Trials on ISPAGHULA HUSK

  • A study to evaluate the effectiveness of ispaghula husk in patients with low anterior resection syndrome after rectal cancer surgery

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Norway

  • Study on the Effects of EMP16 and Ispaghula Husk for Obesity in Adults

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

Glossary

  • Ispaghula husk: A type of soluble fiber derived from the seeds of Plantago ovata plant. Also known as psyllium husk or Plantago ovata husk. Used for various health conditions due to its fiber content.
  • Metabolic syndrome: A cluster of conditions including abdominal obesity, insulin resistance, lipid abnormalities, and high blood pressure that together increase risk of heart disease, stroke, and diabetes.
  • Hypercholesterolemia: A condition characterized by abnormally high levels of cholesterol in the blood, which increases the risk of cardiovascular disease.
  • LDL cholesterol: Low-density lipoprotein cholesterol, often called 'bad' cholesterol, which can build up in blood vessels and increase risk of heart disease.
  • Pharmacokinetics: The study of how drugs move through the body, including absorption, distribution, metabolism, and elimination.
  • Levodopa: A medication used to treat Parkinson's disease by increasing dopamine levels in the brain.
  • Carbidopa: A medication often given with levodopa that prevents levodopa from being broken down before it reaches the brain.
  • Irritable Bowel Syndrome (IBS): A common disorder affecting the large intestine, causing symptoms like abdominal pain, bloating, and altered bowel habits (diarrhea or constipation).
  • Fecal incontinence: The inability to control bowel movements, causing stool to leak unexpectedly from the rectum.
  • Biofeedback: A technique that helps people learn to control bodily functions, such as muscle tension, that are not normally under conscious control.
  • Tibial nerve stimulation: A type of neuromodulation therapy that delivers electrical stimulation to the tibial nerve to help treat conditions like fecal incontinence.
  • Placebo: An inactive substance or treatment that looks like the real medication but contains no active ingredient, used in clinical trials to test the effectiveness of treatments.
  • Double-blind study: A research method where neither the participants nor the researchers know who is receiving which treatment, reducing the risk of bias.
  • HOMA index: Homeostatic Model Assessment, a method for assessing insulin resistance and beta-cell function based on fasting glucose and insulin concentrations.
  • Soluble fiber: A type of dietary fiber that dissolves in water to form a gel-like material in the digestive system, which can help lower blood cholesterol and glucose levels.

References

  1. https://clinicaltrials.gov/study/NCT00748787
  2. https://clinicaltrials.gov/study/NCT00502047
  3. https://clinicaltrials.gov/study/NCT00507715
  4. https://clinicaltrials.gov/study/NCT05867550
  5. https://clinicaltrials.gov/study/NCT02888899